oxycodone/naloxone acino 20 mg / 10 mg depottabletti
acino ag - oxycodoni hydrochloridum,naloxoni hydrochloridum dihydricum - depottabletti - 20 mg / 10 mg - oksikodoni ja naloksoni
agomelatine mylan 25 mg tabletti, kalvopäällysteinen
mylan ab - agomelatine citric acid cocrystal - tabletti, kalvopäällysteinen - 25 mg - agomelatiini
agomelatine stada 25 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - agomelatine citric acid cocrystal - tabletti, kalvopäällysteinen - 25 mg - agomelatiini
dronspot vet 30 mg / 7,5 mg paikallisvaleluliuos
vetoquinol s.a. - praziquantel, emodepside - paikallisvaleluliuos - 30 mg / 7,5 mg - pratsikvanteeli
dronspot vet 60 mg / 15 mg paikallisvaleluliuos
vetoquinol s.a. - praziquantel, emodepside - paikallisvaleluliuos - 60 mg / 15 mg - pratsikvanteeli
dronspot vet 96 mg / 24 mg paikallisvaleluliuos
vetoquinol s.a. - praziquantel, emodepside - paikallisvaleluliuos - 96 mg / 24 mg - pratsikvanteeli
zeposia
bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosuppressantit - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
dalmaprost vet 0.075 mg/ml injektioneste, liuos
fatro s.p.a. - dextrocloprostenol sodium - injektioneste, liuos - 0.075 mg/ml - kloprostenoli
pimotab 1.25 mg purutabletti
cp-pharma handelsgesellschaft mbh - pimobendan - purutabletti - 1.25 mg - pimobendaani
pimotab 2.5 mg purutabletti
cp-pharma handelsgesellschaft mbh - pimobendan - purutabletti - 2.5 mg - pimobendaani